MS Validated Antibodies GmbH

What MS Validated Antibodies GmbH does

MS Validated Antibodies GmbH is a Hamburg-based German biotechnology company that develops and sells primary monoclonal and recombinant antibodies specifically validated for immunohistochemistry (IHC) research applications. Its core technology is a Tissue Microarray (TMA) validation platform on which every antibody is tested against 76 different normal tissue types and numerous cancer tissue types, with orthogonal cross-validation against RNA expression data from the Human Protein Atlas, FANTOM5, and GTEx projects. Each product ships with more than 70 reference images documenting staining performance across normal and cancer tissues, and the antibodies are pre-validated for use on the three major IHC autostainer platforms — Dako Link 48, Leica BOND RX, and Roche Ventana Discovery ULTRA — as well as for multiplex workflows using the AKOYA OPAL dye kit.

The product portfolio centers on individually catalogued antibody clones for clinically and biologically relevant targets — including MTAP (MSVA-741R), PLAP (MSVA-350R), CTLA-4 (MSVA-152R), CPA1 (MSVA-601M), KDM6A (HMV311), Nectin-4 (MSVA-304M), Nucleolin (MSVA-623R), MUC5AC (MSVA-109M), Claudin-6, and TRPS1 — sold as concentrates in 0.1ml, 0.5ml, and 1ml volumes at unit prices ranging from €195 to €2,995. The company also offers tissue microarrays and custom antibody validation services. Revenue is generated through a sales-led, transactional model: direct e-commerce via the company website, supplemented by an international distributor network, with payments processed through Stripe.

The primary customer segments are academic and commercial research laboratories conducting cancer pathology and biomarker research, with a secondary segment in pharmaceutical and biotechnology companies requiring validated antibodies for therapeutic target validation and companion diagnostic development. Scientific credibility is built through peer-reviewed publications in high-impact pathology journals, produced in collaboration with the University of Hamburg and University Medical Center Hamburg-Eppendorf, including studies on cohorts of up to 18,570 tumors across 153 tumor types. The company operates as a privately held GmbH with no disclosed institutional funding, subsidiaries, or external investors; Marco W. Sauter is the legal representative per the Hamburg commercial register.

Name

MS Validated Antibodies GmbH

Legal name

MS Validated Antibodies GmbH

Website

https://ms-validatedantibodies.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

MS Validated Antibodies GmbH is a Hamburg-based German company that develops and sells monoclonal and recombinant antibodies for immunohistochemistry, each validated on tissue microarrays across 76 normal tissue types and numerous cancer types, sold directly online and through international distributors to academic and pharmaceutical research customers.

Ownership category

akta.pro rank

Product category

Research Antibodies

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

akta.pro secondary industries

Immuno-Oncology & Immune Monitoring Biomarkers (TMB, MSI, MRD, immune profiling) (HLAAAMAK), Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Validated antibodies
• Immunohistochemistry reagents
• Tissue microarrays
• Antibody validation services
• Cancer biomarkers

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Antibody Product Sales: Direct sales of validated primary antibodies for immunohistochemistry research. Products sold as concentrates in 0.1ml, 0.5ml, and 1ml volumes. One-time purchase model with repeat orders for consumable research reagents.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

MS Validated Antibodies GmbH develops, validates, and sells recombinant and monoclonal primary antibodies for immunohistochemistry (IHC) research. Each antibody is validated on tissue microarrays covering 76 normal tissue types and numerous cancer tissue types, with unique documentation of more than 70 images per product. The company also offers tissue microarrays and custom antibody validation services for research laboratories, pathology institutions, and pharmaceutical/biotech customers.

Product overview

MS Validated Antibodies GmbH is a biotechnology company specializing in large-scale validated antibodies specifically designed for immunohistochemistry (IHC). The company offers a portfolio of primary antibodies validated on tissue microarrays containing 76 different normal tissues and numerous cancer tissue types. Each product includes unique documentation with over 70 images showing antibody performance. The product portfolio includes individual antibody products (such as MTAP, Claudin-6, TRPS1, PLAP, Nectin-4, CTLA-4, CPA1, KDM6A, Nucleolin, MUC5AC), antibody validation services, and tissue microarrays. The company publishes large-scale studies demonstrating antibody specificity and utility in cancer research applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Primary Antibodies Portfolio
• CTLA-4 / CD152 (MSVA-152R)
• Carboxypeptidase A1 / CPA1 (MSVA-601M)
• Nectin-4 (MSVA-304M)
• PLAP (MSVA-350R)
• KDM6A (HMV311)
• Nucleolin (MSVA-623R)
• MUC5AC (MSVA-109M)
• Tissue Microarrays
• Antibody Validation Services

Quantifiable outcome

• CPA1 antibody shows >99% sensitivity and specificity for acinar cell carcinoma of the pancreas in study of 15,680 tumors
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability2 records

Feature6 records

Partnerships

One partnership is on record.

• ardoci GmbHcoreTechnology or Integrationardoci GmbH provides technology powering the HMV311 recombinant antibody clone (KDM6A). The HMV311 antibody used in MSVA products is developed using ardoci's technology platform, demonstrating a technology integration partnership for antibody development.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Rockland Immunochemicals: US-based supplier of antibodies and antibody-based tools for research and diagnostic applications. Comparable private-company scale peer serving the same IHC and immunoassay research customer base.
• Santa Cruz Biotechnology: US-based antibody supplier with a wide catalog of monoclonal and polyclonal antibodies for research use, including IHC applications. Direct peer in the research-use antibody market, with comparable products but a different validation depth strategy.
• Atlas Antibodies: Swedish company that develops and sells highly validated antibodies, particularly the Triple A Polyclonal antibody portfolio backed by the Human Protein Atlas. Most directly comparable peer — narrow, scientifically credible catalog emphasizing IHC validation and tissue-based documentation.
• BioLegend: Manufacturer of antibodies and reagents for life science research, including IHC-relevant clones. Part of the broader Revvity/PerkinElmer ecosystem; relevant peer for immunology-focused antibodies such as CTLA-4.

Broad incumbents

• Abcam: Global antibody reagent leader (now part of Danaher) with an extensive catalog of primary antibodies and supporting validation data. Competes with MSVA in the IHC research-reagent market, with much broader catalog depth and a stronger pharma footprint.
• Thermo Fisher Scientific (Antibody & IHC portfolio): Operates the Invitrogen and Lab Vision antibody brands and is a leading supplier of IHC reagents and autostainer platforms. Dominant broad incumbent with overlapping products and platform compatibility overlap with MSVA clones.
• Cell Signaling Technology: Major US-based antibody manufacturer with a very large catalog of validated antibodies for IHC, WB, and other applications. Operates in the same product category with overlapping customers but at far greater scale and broader application scope.
• Merck KGaA / Sigma-Aldrich (Life Science): Major life-science tools supplier with a broad antibody and reagent catalog under the Sigma-Aldrich and MilliporeSigma brands. Relevant incumbent competitor and also a potential distribution channel comparator for MSVA's catalog.

Regional players

• Progen Biotechnik: German-based antibody and reagent specialist serving the European pathology and research market. Comparable niche position with overlapping customer base in Germany; useful regional peer for European pricing and distribution dynamics.

Others

• Agilent Technologies (Dako): Owns the Dako IHC autostainer platform, on which MSVA antibodies are validated. Acts as both an ecosystem enabler for MSVA's workflow and a competitor through its own antibody and PD-L1 companion diagnostic products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ms-validated-antibodies-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MS Validated Antibodies GmbH